Merrimack Pharmaceuticals, Inc. Price & Performance (MACK)

Swiss pharmaceutical giant Roche announced a sweeping $50 billion investment in the U.S. over the next five years. The initiative will fund research, development, and manufacturing sites across several states, adding 12,000 jobs and expanding Roche’s American footprint to 24 sites in eight states.1

Enterprise Bancorp posted a 22.4% year-over-year increase in net income for Q1 2025, driven by loan growth but offset by declining core deposits and rising non-performing loans. The merger with Rockland Trust remains on track for completion in the second half of 2025, with integration planning underway.2

A new study reveals that administering immunotherapy both before and after surgery leads to significantly better outcomes for patients with head and neck cancer. The approach reduced recurrence rates and improved survival, marking a promising advance in cancer treatment protocols and patient care.3